Gentian Diagnostics ASA (OSL:GENT)
46.80
+1.80 (4.00%)
Apr 16, 2025, 1:05 PM CET
Gentian Diagnostics ASA Revenue
In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M NOK with 12.52% growth. Gentian Diagnostics ASA had revenue of 42.61M in the quarter ending December 31, 2024, with 13.73% growth.
Revenue
152.07M
Revenue Growth
+12.52%
P/S Ratio
4.75
Revenue / Employee
2.41M
Employees
63
Market Cap
721.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 152.07M | 16.92M | 12.52% |
Dec 31, 2023 | 135.15M | 23.23M | 20.76% |
Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
Dec 31, 2020 | 78.88M | 23.50M | 42.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 556.16M |
Nordhealth AS | 537.23M |
Photocure ASA | 525.39M |
Vistin Pharma ASA | 429.50M |
ArcticZymes Technologies ASA | 108.11M |
Hofseth BioCare ASA | 265.54M |
Omda AS | 426.27M |
Nykode Therapeutics AS | 104.04M |